Tag: profitrises

IT primary Infosys Ltd on Thursday reported an 11% jump in consolidated net profit at Rs 6,021 crore for the quarter ending September 30, 2022, up 11.1 percent from Rs 5,421 core reported in the same quarter of the previous year. It reported a 23.4 percent YoY jump in consolidated revenue for the September quarter to Rs 36,538 crore as against Rs 29,602 crore in Q2FY22. Numbers were in-line with projections. A poll of analysts had projected a 24 percent year-on-year (YoY) growth in revenue and 11 percent in net profit. Infosys has also announced a share buyback worth Rs 9,300 crore. Under the buyback program, the price will not exceed Rs 1,850 per equity share. The price is 30% higher than the company shares' closing price of Rs 1,422 apiece on Thursday. The IT major will also pay an interim dividend totaling Rs 6,940 crore to the shareholders at Rs 16.5 per equity share. Read more

Shares of Sun Pharmaceutical Industries Ltd gained 2.5 percent on January 31 after the company reported an 11% rise in its consolidated net profit to Rs 2,058.80 crore in the December quarter. The pharma major had reported a net profit of ₹1,852 crores in the December quarter of last year. Consolidated net sales for the quarter increased 11.41% from a year ago to Rs 9,814.17 crore. Total cost advanced 12% to Rs 7,829.38 crore. The company's board has also declared an interim dividend of ₹7 for the financial year ending on March 31, 2022. Operating EBITDA margin declined sharply to 17.12% in the quarter from 20.43% a quarter ago and 20.97% a year ago. The sale of formulations in the domestic market during the third quarter was at ₹3,167 crores, up by 15% over last year and accounting for 32% of total sales. Read more